Rare diseases
Investigational molecules
Locations
Back to Germany31 clinical trials in Elsterwerda, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in GermanyKlinischeStudien.de(opens in a new tab)Effect of zenagamtide on major adverse cardiovascular events in overweight or obese adults with established atherosclerotic cardiovascular disease
GermanyA Phase III Randomized Double‑Blind Study of Elecoglipron for Adults with Type 2 Diabetes on Insulin
GermanyA Phase III Study of Elecoglipron Compared with Semaglutide for Adults with Type 2 Diabetes Mellitus
GermanyZenagamtide Compared with Semaglutide in Adults with Overweight or Obesity and Type 2 Diabetes
GermanyStudy of Zilebesiran Added to Standard Treatment to Reduce Heart Problems in Adults with High Blood Pressure and Heart Disease Risk
GermanyGermanyPhase 3 Extension Trial Evaluating Long‑Term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity
GermanyLong‑term Efficacy, Safety and Tolerability of maridebart cafraglutide in Adults with Obesity and Type 2 Diabetes
GermanyEffect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)
GermanyZenagamtide for Weight Loss in Adults with Obesity
GermanyStudy of Zenagamtide (NNC0487-0111) versus placebo in patients with heart failure with preserved or mildly reduced ejection fraction and obesity
GermanyStudy on Balcinrenone and Dapagliflozin for Patients with Heart Failure and Kidney Problems
GermanyThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on weight management and Type 2 Diabetes treatments, evaluating innovative therapies for improved metabolic outcomes.
Studies combining lifestyle modifications with novel therapeutic approaches for comprehensive metabolic health improvement.
Research targeting atherosclerotic cardiovascular disease and innovative treatments for various forms of heart failure.
Comprehensive evaluation of new therapeutic agents for both preserved and reduced ejection fraction heart failure.
Advanced clinical research examining treatments for resistant hypertension and atrial fibrillation, focusing on innovative therapeutic approaches.
Evaluating next-generation medications for better control of complex cardiovascular conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
